摘要
目的:促进中药注射剂的合理应用。方法:对我院2011-2013年中药注射剂的销售金额、用药频度(DDDs)及药品日均费用(DDC)进行统计分析。结果:2011-2013年中药注射剂的销售金额和DDDs逐年增加,其中销售金额年增长率分别为14.82%和25.34%,DDDs年增长率分别达12.05%和26.30%;心脑血管类中药注射剂销售金额和DDDs在各年度排序位居首位;痰热清注射剂DDDs增长最快,2013年位居首位;参麦注射剂与苦碟子注射剂各年度DDDs均位于前3位;抗肿瘤类中药注射剂DDC较高,其中以康莱特注射剂最高。结论:我院中药注射剂应用基本合理且呈不断增长趋势,但部分中药注射剂可能存在过度使用,应加强其合理使用的监管,确保其临床使用安全、有效。
OBJECTIVE： To promote rational use of TCM injection. METHODS： The utilization of TCM injection in our hospital from 2011 to 2013 was statistically analyzed in respects of consumption sum, DDDs and DDC. RESULTS： The consumption sum and DDDs of TCM injection was increased year by year during 2011-2013; annual increase rates of consumption sum were 14.82% and 25.34%, and that of DDDs were 12.05% and 26.30%, respectively. The cardiovascular TCM injection dominated the first place in terms of consumption sum and DDDs for the three years. The increase of Tanreqing injection in DDDs was the fastest and dominated the first place in 2013; Shenmai injection and Kudiezi injection took the top three places in the list of DDDs. TCM injection for anti-tumor took up the leading place in DDC, and that of Kanglaite injection was the highest. CONCLUSIONS： The utilization of TCM injection in the hospital is reasonable basically and increases year by year. Overuse of TCM injection is found in some types, and supervision on rational use of TCM injection should be strengthened to guarantee safe and effective use of TCM injection.
出处
《中国药房》
CAS
CSCD
2014年第31期2955-2958,共4页
China Pharmacy
